Patents Assigned to VISIBLE GENOMICS, LLC
  • Methods to determine carcinogenesis, identify markers for early cancer diagnosis and identify targets of therapy
    Patent number: 11085083
    Abstract: Methods and techniques to identify carcinogenesis pathways and markers for early cancer diagnosis. Cell sampling is performed on a single tumor with multiple samples being taken from the tumor and outward toward the periphery and beyond. Large scale analysis is performed, such as whole genomic sequencing, to identify the differences between the cells of the various samples. The differences are evaluated to determine which differences represent a change along the carcinogenesis pathway.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: August 10, 2021
    Assignee: VISIBLE GENOMICS, LLC
    Inventors: James M. Barbeau, John S. DePaolo